Richard J. Wadas
Emergency Medicine
631 North Broad Street Extension, Grove City Hospital
Grove City, PA 16127
Grove City, PA 16127
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Corrigendum to "Design and methods of an adaptive trial to test comparative effectiveness of readmission reduction approaches following infection and sepsis hospitalizations (ACCOMPLISH)" [Contemp. Clinic. Trials Commun. 46 (2025) 101504].
Journal: Contemporary clinical trials communications
Published: July 29, 2025
Design and methods of an adaptive trial to test comparative effectiveness of readmission reduction approaches following infection and sepsis hospitalizations (ACCOMPLISH).
Journal: Contemporary clinical trials communications
Published: January 15, 2025
Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.
Journal: Annals of internal medicine
Published: April 03, 2023
Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.
Journal: Open forum infectious diseases
Published: August 10, 2022
Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.
Journal: JAMA network open
Published: July 14, 2022
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.
Journal: JAMA network open
Published: April 12, 2022
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.
Journal: Contemporary clinical trials
Published: February 24, 2022
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment.
Journal: Journal of the American College of Emergency Physicians open
Published: June 26, 2021
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
Journal: Contemporary clinical trials
Published: June 18, 2021
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.
Journal: Trials
Published: May 01, 2021
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Journal: Open forum infectious diseases
Published: April 30, 2021
Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic.
Journal: Open forum infectious diseases
Published: January 19, 2021
Last Updated: 09/26/2026